ARTICLE | Distillery Therapeutics
Renal
January 3, 2019 1:47 PM UTC
Mouse studies suggest inhibiting AKR1A1 or PKM2 could help treat acute kidney injury (AKI). In a mouse model of AKI, systemic AKR1A1 knockout or renal-specific PKM2 knockout increased survival and dec...
BCIQ Company Profiles
BCIQ Target Profiles